# AI Guidance for Biopsy in Suspected Cholangiocarcinoma

> **NCT05374122** · NA · UNKNOWN · sponsor: **Instituto Ecuatoriano de Enfermedades Digestivas** · enrollment: 48 (estimated)

## Conditions studied

- Neoplasms
- Non-Neoplastic
- Bile Duct Neoplasms
- Bile Duct Lesions

## Interventions

- **DIAGNOSTIC_TEST:** DSOC with AI biopsy guidance
- **DIAGNOSTIC_TEST:** DSOC biopsy without AI guidance

## Key facts

- **NCT ID:** NCT05374122
- **Lead sponsor:** Instituto Ecuatoriano de Enfermedades Digestivas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-05-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05374122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05374122, "AI Guidance for Biopsy in Suspected Cholangiocarcinoma". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05374122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*